famotin tablet 20 mg
teva pharmaceutical investments singapore pte. ltd. - famotidine - tablet - 20 mg - famotidine 20 mg
famotin tablet 40 mg
teva pharmaceutical investments singapore pte. ltd. - famotidine - tablet - 40 mg - famotidine 40 mg
famotin tablet
prime pharmaceutical sdn. bhd. - famotidine -
famotin 20 tablet
doctor's chemicals works ltd. - famotidine - tablet - 20 mg
famotin 40 tablet
doctor's chemicals works ltd. - famotidine - tablet - 40 mg
famotidine tablet
bluepoint laboratories - famotidine (unii: 5qzo15j2z8) (famotidine - unii:5qzo15j2z8) - famotidine tablets are indicated in adult and pediatric patients 40 kg and above for the treatment of: - active duodenal ulcer (du). - active gastric ulcer (gu). - symptomatic nonerosive gastroesophageal reflux disease (gerd). - erosive esophagitis due to gerd, diagnosed by biopsy. famotidine tablets are indicated in adults for the: - treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome, multiple endocrine neoplasias). - reduction of the risk of duodenal ulcer recurrence. famotidine tablets are contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other histamine-2 (h 2 ) receptor antagonists. risk summary available data with h 2 -receptor antagonists, including famotine, in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. in animal reproduction studies, no adverse development effects were observ
famotin -20 tablet
famotidine 200mg
famotin forte tablet
famotidine 400mg